Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by LifeStance Health Group, Inc. on June 3, 2025. The filing details the voting results for three proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
The following proposals were voted upon at the Annual Meeting:
- Proposal 1: Election of Directors (Class I)
- Teresa DeLuca: Elected (292,308,309 For; 30,914,443 Withhold).
- Katherine Wood: Elected (245,528,506 For; 77,694,246 Withhold).
- Eric Palmer: Elected (318,312,297 For; 4,910,455 Withhold).
- Note: All nominees received significant support, though Katherine Wood faced higher withhold votes compared to other nominees.
- Proposal 2: Ratification of Independent Auditor
- PricewaterhouseCoopers LLP was ratified for the year ended December 31, 2025.
- Results: 346,473,203 For; 58,358 Against; 671,238 Abstain.
- Proposal 3: Advisory Vote on Executive Compensation
- Stockholders approved the named executive officer compensation on a non-binding basis.
- Results: 295,914,020 For; 26,682,137 Against; 626,595 Withhold.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the specific compensation plan details referenced in Proposal 3 to understand the basis for the advisory vote.
- Confirm the tenure and background of the newly elected Class I directors (DeLuca, Wood, Palmer).
- Check subsequent filings for the full proxy statement containing detailed management discussion on the voting results.